The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.03.080PMID 27062428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel RAAS agonists and antagonists: clinical applications and controversies

  2015cited by this paper
• Current role of neprilysin inhibitors in hypertension and heart failure.

  2014cited by this paper
• Circulating aminopeptidase activities in men and women with essential hypertension.

  2013cited by this paper
• Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

  2013cited by this paper
• Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.

  2013cited by this paper
• Update on the Angiotensin Converting Enzyme 2-Angiotensin (1–7)-Mas Receptor Axis: Fetal Programing, Sex Differences, and Intracellular Pathways

  2013cited by this paper
• Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy

  2013cited by this paper
• Is there benefit in dual renin– angiotensin–aldosterone system blockade? No, yes and maybe: A guide for the perplexed

  2013cited by this paper
• Epidemiology of Heart Failure

  2013cited by this paper
• New advances in beta-blocker therapy in heart failure

  2013cited by this paper
• Discovery of Inhibitors of Insulin-Regulated Aminopeptidase as Cognitive Enhancers

  2012cited by this paper
• Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• AT2 receptor agonists: hypertension and beyond

  2012cited by this paper
• Natriuretic peptide metabolism, clearance and degradation

  2011cited by this paper
• The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

  2011cited by this paper
• GRK2 as a novel gene therapy target in heart failure.

  2011cited by this paper
• Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure

  2011cited by this paper
• Reconsidering the Roles of the Mineralocorticoid Receptor

  2009cited by this paper
• The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.

  2009cited by this paper
• Natriuretic peptides in vascular physiology and pathology.

  2008cited by this paper
• Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure

  2008cited by this paper
• Brain mechanisms contributing to sympathetic hyperactivity and heart failure.

  2007cited by this paper
• ANGIOTENSIN II RECEPTORS SUBTYPES MEDIATE DIVERSE GENE EXPRESSION PROFILE IN ADULT HYPERTROPHIC CARDIOMYOCYTES

  2007cited by this paper
• Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure

  2007cited by this paper
• Natriuretic peptides.

  2007cited by this paper
• Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

  2006cited by this paper
• Physiology of local renin-angiotensin systems.

  2006cited by this paper
• Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes

  2003cited by this paper
• Mechanisms of renal hyporesponsiveness to ANP in heart failure

  2003cited by this paper
• Neutral Endopeptidase Is Activated in Cardiomyocytes in Human Aortic Valve Stenosis and Heart Failure

  2002cited by this paper
• beta-adrenergic receptor blockade in chronic heart failure.

  2000cited by this paper
• β-Adrenergic Receptor Blockade in Chronic Heart Failure

  2000cited by this paper
• Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

  1999cited by this paper
• N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.

  1998cited by this paper
• Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.

  1998cited by this paper
• Biochemical detection of left-ventricular systolic dysfunction.

  1998cited by this paper
• Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.

  1998cited by this paper
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

  1997cited by this paper
• Apoptosis in the failing human heart.

  1997cited by this paper
• Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.

  1997cited by this paper
• Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

  1996cited by this paper
• The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides

  1996cited by this paper
• Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression.

  1996cited by this paper
• Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gsα Overexpression

  1996cited by this paper
• The natriuretic peptides in heart failure

  1994cited by this paper
• C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

  1990cited by this paper
• Atrial natriuretic peptides and renin release.

  1988cited by this paper
• A new natriuretic peptide in porcine brain

  1988cited by this paper
• Physiological role of silent receptors of atrial natriuretic factor.

  1987cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• The purification and specificity of a neutral endopeptidase from rabbit kidney brush border.

  1974cited by this paper

• Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases

  2026cites this paper
• Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis

  2025cites this paper
• Research Progress in Cardiovascular Autonomic Dysfunction in Patients with Heart Failure

  2025cites this paper
• The hidden role of left atrial strain: insights into end-organ damage in dipper and nondipper hypertension

  2025cites this paper
• Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models

  2024cites this paper
• Acute Kidney Injury and Subsequent Cardiovascular Disease: Epidemiology, Pathophysiology, and Treatment.

  2024cites this paper
• New and future heart failure drugs

  2024influential citation
• Cardio-oncological dialogue: Understanding the mechanistic correlation between heart failure and cancer.

  2024cites this paper
• A perspective on the development of small molecular neprilysin inhibitors (NEPi) with emphasis on cardiorenal disease.

  2024cites this paper
• Recombinant human angiotensin-converting enzyme 2 plays a protective role in mice with sepsis-induced cardiac dysfunction through multiple signaling pathways dependent on converting angiotensin II to angiotensin 1–7

  2023cites this paper
• Progress and prospects of Sacubitril/Valsartan: Based on heart failure with preserved ejection fraction.

  2022cites this paper
• New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review

  2022cites this paper
• Aldosterone dysregulation predicts the risk of mortality and rehospitalization in heart failure with a preserved ejection fraction

  2021cites this paper
• The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19

  2021cites this paper
• Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure

  2021cites this paper
• Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias

  2021influential citation
• Acute and Chronic Effects of COVID-19 on the Cardiovascular System

  2021cites this paper
• Alamandine: Potential Protective Effects in SARS-CoV-2 Patients

  2021cites this paper
• Current and future therapeutic perspective in chronic heart failure.

  2021cites this paper
• Angiotensin (1-7)-attenuated vasoconstriction is associated with the Interleukin-10 signaling pathway.

  2020cites this paper
• Ambient fine particulate matter induced the elevation of blood pressure through ACE2/Ang(1-7) pathway: The evidence from urine metabolites.

  2020cites this paper
• Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure

  2020cites this paper
• Novel pharmacotherapies for heart failure

  2020cites this paper
• Salsolinol Attenuates Doxorubicin-Induced Chronic Heart Failure in Rats and Improves Mitochondrial Function in H9c2 Cardiomyocytes

  2019cites this paper
• Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?

  2019cites this paper
• Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure

  2019cites this paper
• BNP as a Major Player in the Heart-Kidney Connection

  2019cites this paper
• Neprilysin inhibitor from herbal compounds as the latest adjuvant treatment of chronic heart failure

  2019cites this paper
• Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang

  2019cites this paper
• Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.

  2018cites this paper
• The Role of Renal Vascular Reactivity in the Development of Renal Dysfunction in Compensated and Decompensated Congestive Heart Failure

  2018cites this paper
• Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure.

  2017cites this paper
• New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): Focus on cardiovascular and neurological diseases.

  2017cites this paper
• Insights of Chinese medicine on ventricular remodeling: Multiple-targets, individualized-treatment

  2017cites this paper
• Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure.

  2017cites this paper
• The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure.

  2016cites this paper
• Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure (cid:2)

  year unknowncites this paper